Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence

INTRODUCTION: Current evidence shows that serum miR-371a-3p can identify disease recurrence in testicular germ cell tumour (TGCT) patients and correlates with tumour load. Despite convincing evidence showing the advantages of including miR-371a-3p testing to complement and overcome the classical ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Christiansen, Ailsa J., Lobo, João, Fankhauser, Christian D., Rothermundt, Christian, Cathomas, Richard, Batavia, Aashil A., Grogg, Josias B., Templeton, Arnoud J., Hirschi-Blickenstorfer, Anita, Lorch, Anja, Gillessen, Silke, Moch, Holger, Beyer, Jörg, Hermanns, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773982/
https://www.ncbi.nlm.nih.gov/pubmed/36568207
http://dx.doi.org/10.3389/fonc.2022.1056823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773982/
https://www.ncbi.nlm.nih.gov/pubmed/36568207
http://dx.doi.org/10.3389/fonc.2022.1056823

Ejemplares similares